CAS: 1346572-63-1
N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-3-methyl-6-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide
CAS:1346572-63-1
Formula:
C31H38N6O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
526.6724
Ref: IN-DA009BPA
| 5mg | 118.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
GSK503
CAS:1346572-63-1
GSK-503, a potent EZH2 inhibitor, has potential antitumor activity.
Formula:
C31H38N6O2
Purity:
98% - 99.74%
Color and Shape:
Solid
Molecular weight:
526.67
Ref: TM-T1775
| 1mg | 36.00 € | ||
| 2mg | 52.00 € | ||
| 5mg | 78.00 € | ||
| 10mg | 109.00 € | ||
| 25mg | 204.00 € | ||
| 50mg | 368.00 € | ||
| 100mg | 551.00 € | ||
| 500mg | 1,188.00 € | ||
| 1mL*10mM (DMSO) | 92.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
GSK 503
CAS:1346572-63-1
Inhibits EZH2 methyltransferase; antineoplastic
Formula:
C31H38N6O2
Purity:
Min. 95%
Color and Shape:
Solid
Molecular weight:
526.30562
Ref: 3D-FG137681
| 10mg | 271.00 € | ||
| 50mg | 678.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
GSK503
Controlled ProductCAS:1346572-63-1
Formula:
C31H38N6O2
Color and Shape:
Neat
Molecular weight:
526.67
Ref: TR-G797660
| 500mg | 15,185.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
